ABSTRACT
Realizamos una prospectiva básica, con datos al 21/03/2020 de la evolución del número de casos COVID-19 diarios en Chile con datos del Ministerio de Salud. Asumiendo un crecimiento aritmético en la segunda variación de los datos, se presenta un modelo de ajuste cúbico que estima en más de 100 mil casos a 120 días y que es consistente con los datos registrados a la fecha. Además, se interviene un modelo de casos totales exponencial, para representar en él (mediante un parámetro) el esfuerzo diario por rebajar una elevada primera tasa de crecimiento diario. Este modelo se simula con distinto escenarios numéricos de factibilidad y prevalencia futura deseada.
We present a straightforward projection with data up to 21/03/2020 of the evolution of the number of COVID-19 cases per day in Chile using data from the Ministry of Health. Assuming an arithmetical growth in the second variation of the data, we present a cubic adjustment model in which we estimate over 100 000 cases at 120 days consistent with the data recorded to date. Furthermore, we use an exponential total case model to represent (using a parameter) the daily effort to reduce a high initial daily growth rate. We simulate this model with different numerical scenarios of feasibility and desired future prevalence.
Subject(s)
Humans , Disease Outbreaks , Models, Statistical , SARS-CoV-2 , COVID-19/epidemiology , Chile/epidemiology , Prevalence , PandemicsABSTRACT
Gastric cancer (GC) is the third most lethal type of cancer worldwide. Single nucleotide polymorphisms (SNPs) in regulatory sites or coding regions can modify the expression of genes involved in gastric carcinogenesis, as ERBB2, which encodes for the tyrosine-kinase receptor HER-2. The aim of this work was to analyze the association of the polymorphisms: rs2643194, rs2517951, rs2643195, rs2934971, and rs1058808 with GC, as they have not yet been analyzed in GC patients, as well as to report their frequency in the general Mexican population (GMP). We studied genomic DNA from subjects with GC (n=74), gastric inflammatory diseases (GID, n=76 control subjects), and GMP (n=102). Genotypes were obtained by means of real-time PCR and DNA-sequencing. The risks for GC were estimated through odds ratio (OR) using the Cochran-Armitage trend test and multinomial logistic regression. Increased risk for GC was observed under the dominant inheritance model for the rs2643194 TT or CT genotypes with an OR of 2.75 (95%CI 1.12−6.75, P=0.023); the rs2934971 TT or GT genotypes with an OR of 2.41 (95%CI 1.01−5.76, P=0.043), and the rs1058808 GG or CG genotypes with an OR of 2.21 (95%CI 1.00−4.87, P=0.046). The SNPs rs2643194, rs2934971, and rs1058808 of the ERBB2 gene were associated with increased risk for GC.
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Young Adult , Stomach Neoplasms/genetics , Adenocarcinoma/genetics , Receptor, ErbB-2/genetics , Polymorphism, Single Nucleotide/genetics , Case-Control Studies , Polymerase Chain Reaction , Genetic Predisposition to Disease , GenotypeABSTRACT
Al ser controladas las arritmias como causa inmediata de muerte post-infarto, los pacientes fallecen de las complicaciones mecanicas del mismo. Desde 1972 hasta la fecha se han intervenido en el Hospital Mexico 13 hombres portadores de aneurisma ventricular post-infarto. No hubo mortalidad operatoria alguna. Los procedimientos realizados en este grupo de pacientes incluyeron la reseccion del aneurisma y la revascularizacion coronaria complementaria Doce pacientes han mejorado notablemente de su clase funcional preoperatoria